CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

5 hedge funds and large institutions have $1.59M invested in Can-Fite BioPharma in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$57K
2
+$6K
3
+$1K

Top Sellers

1
-$100K
2
-$34K
3
-$29K
4
UBS Group
UBS Group
Switzerland
-$6K
5
Morgan Stanley
Morgan Stanley
New York
-$4.67K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.53M
2
$57K
3
$6K
4
$1K
5
$1K
6
–
7
–
8
–
9
–